NASDAQ:AMPH
Amphastar Pharmaceuticals Stock News
$42.33
+0.180 (+0.427%)
At Close: May 31, 2024
The Global Preclinical Respiration and Inhalation Lab Equipment Market will grow by $ 2.26 mn during 2020-2024
Amphastar Pharmaceuticals (AMPH) Presents at Wells Fargo Securities 2020 Virtual Healthcare Conference - Slideshow
05:42pm, Friday, 11'th Sep 2020
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this event..
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020
08:05pm, Thursday, 06'th Aug 2020
Reports Net Revenues of $85.8 Million for the Three Months Ended June 30, 2020RANCHO CUCAMONGA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar�
Amphastar Pharmaceuticals's Earnings: A Preview
04:18pm, Wednesday, 05'th Aug 2020
On Thursday, August 06, Amphastar Pharmaceuticals (NASDAQ: AMPH) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.Earnings an
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Short Interest Down 6.7% in July
03:44am, Tuesday, 04'th Aug 2020
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) was the target of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 2,630,000 shares, a dec
Here's What Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Shareholder Ownership Structure Looks Like
12:05pm, Monday, 03'rd Aug 2020
If you want to know who really controls Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), then you'll have to look at the...
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
08:05pm, Thursday, 30'th Jul 2020
RANCHO CUCAMONGA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June 30,
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
04:33pm, Wednesday, 29'th Jul 2020
Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Stock Holdings Lifted by AQR Capital Management LLC
08:00am, Saturday, 04'th Jul 2020
AQR Capital Management LLC lifted its position in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) by 130.4% during the 1st quarter, according to the company in its most recent disclosure with the Securiti
Are Robust Financials Driving The Recent Rally In Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock?
03:59pm, Friday, 03'rd Jul 2020
Amphastar Pharmaceuticals (NASDAQ:AMPH) has had a great run on the share market with its stock up by a significant 48...
Needham Downgrades Zynerba Pharmaceuticals (ZYNE) to Hold - Markets
11:24am, Wednesday, 01'st Jul 2020
In a report released today, Serge Belanger from Needham downgraded Zynerba Pharmaceuticals (ZYNE – Research Report) to Hold. The company’s
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:13am, Wednesday, 01'st Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on G1 Therapeutics
Northland Securities Maintains a Buy Rating on Verrica Pharmaceuticals (VRCA) - Markets
11:49am, Tuesday, 30'th Jun 2020
Northland Securities analyst Tim Chiang maintained a Buy rating on Verrica Pharmaceuticals (VRCA – Research Report) today and set a
Analysts Are Bullish on These Healthcare Stocks: Verrica Pharmaceuticals (VRCA), Intercept Pharma (ICPT) - Markets
10:08am, Tuesday, 30'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Verrica Pharmaceuticals
Needham Assigns a Buy Rating on Zogenix (ZGNX) - Markets
10:00am, Monday, 29'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Zogenix (ZGNX – Research Report), with
